| 1 |
Schenk-Jaeger KM, Rauber-Lüthy C, Bodmer M, et al. Mushroom poisoning: a study on circumstances of exposure and patterns of toxicity[J]. Eur J Intern Med, 2012, 23 (4): e85-e91.
|
| 2 |
Poucheret P, Fons F, Doré JC, et al. Amatoxin poisoning treatment decision-making: pharmaco-therapeutic clinical strategy assessment using multidimensional multivariate statistic analysis[J]. Toxicon, 2010, 55 (7): 1338-1345.
|
| 3 |
Karvellas CJ, Tillman H, Leung AA, et al. Acute liver injury and acute liver failure from mushroom poisoning in North America[J]. Liver Int, 2016, 36 (7): 1043-1050.
|
| 4 |
付萍，刘志涛，梁骏华，等. 2014年中国大陆食源性疾病暴发事件监测资料分析[J].中国食品卫生杂志，2018，30(6):628-634.
|
| 5 |
Sun J, Niu YM, Zhang YT, et al. Toxicity and toxico-kinetics of Amanita exitialis in beagle dogs[J]. Toxicon, 2018 (143): 59-67.
|
| 6 |
孙亮，陈莉莉，廖宁波，等. 2010-2016年浙江省毒蘑菇中毒流行病学分析[J].中国食品卫生杂志，2018，30(3):270-274.
|
| 7 |
张黎光，李峻志，祁鹏，等.毒蕈中毒及治疗方法研究进展[J].中国食用菌，2014，33(5):1-5.
|
| 8 |
文莉，欧三桃.鹅膏毒菌的研究现状及展望[J].西南军医，2019，21(2):142-146.
|
| 9 |
Yilmaz I, Kaya E, Sinirlioglu ZA, et al. Clinical importance of toxin concentration in Amanita verna mushroom[J]. Toxicon, 2014 (87): 68-75.
|
| 10 |
Graeme KA. Mycetism: a review of the recent literature[J]. J Med Toxicol, 2014, 10 (2): 173-189.
|
| 11 |
Yilmaz I, Ermis F, Akata I, et al. A case study: what doses of amanita phalloides and amatoxins are lethal to humans?[J]. Wilderness Environ Med, 2015, 26 (4): 491-496.
|
| 12 |
Faulstich H, Talas A, Wellhoner HH. Toxicokinetics of labeled amatoxins in the dog[J]. Arch Toxicol, 1985, 56 (3): 190-194.
|
| 13 |
Jaeger A, Jehl F, Flesch F, et al. Kinetics of amato-xins in human poisoning: therapeutic implications[J]. J Toxicol Clin Toxicol, 1993, 31 (1): 63-80.
|
| 14 |
Shively RM, Nogar JN, Rella JG, et al. Got milk? A case series of an amatoxin-exposed family, including a breastfeeding mother and infant[J]. Clin Toxicol (Phila), 2019: 1-2.
|
| 15 |
Garcia J, Carvalho AT, Dourado DF, et al. New in silico insights into the inhibition of RNAP Ⅱ by alpha-amanitin and the protective effect mediated by effective antidotes[J]. J Mol Graph Model, 2014 (51): 120-127.
|
| 16 |
Letschert K, Faulstich H, Keller D, et al. Molecular characterization and inhibition of amanitin uptake into human hepatocytes[J]. Toxicol Sci, 2006, 91 (1): 140-149.
|
| 17 |
Magdalan J, Piotrowska A, Gomulkiewicz A, et al. Benzylpenicyllin and acetylcysteine protection from α-amanitin-induced apoptosis in human hepatocyte cultures[J]. Exp Toxicol Pathol, 2011, 63 (4): 311-315.
|
| 18 |
Durand F, Valla D. Chapter 34 - Mushroom poisoning: a clinical model of toxin-induced centrilobular necrosis[M]//Kaplowitz Neil, DeLeve LD. Drug-induced liver disease. 3rd ed. Amsterdam: Elsevier, 2013: 621-629.
|
| 19 |
Wang M, Chen Y, Guo Z, et al. Changes in the mitochondrial proteome in human hepatocytes in response to alpha-amanitin hepatotoxicity[J]. Toxicon, 2018 (156): 34-40.
|
| 20 |
Barman B, Warjri S, Lynrah KG, et al. Amanita nephrotoxic syndrome: presumptive first case report on the indian subcontinent[J]. Indian J Nephrol, 2018, 28 (2): 170-172.
|
| 21 |
Ganzert M, Felgenhauer N, Schuster T, et al. Amanita poisoning--comparison of silibinin with a combination of silibinin and penicillin[J]. Dtsch Med Wochenschr, 2008, 133 (44): 2261-2267.
|
| 22 |
Trabulus S, Altiparmak MR. Clinical features and outcome of patients with amatoxin-containing mushroom poisoning[J]. Clin Toxicol (Phila), 2011, 49 (4): 303-310.
|
| 23 |
Escoda O, Reverter E, To-Figueras J, et al. Potential value of urinary amatoxin quantification in patients with hepatotoxic mushroom poisoning[J]. Liver Int, 2019, 39 (6): 1128-1135.
|
| 24 |
Thiel K, Schenk M, Sipos B, et al. Acute liver failure after amanitin poisoning: a porcine model to detect prognostic markers for liver regeneration[J]. Hepatol Int, 2014, 8 (1): 128-136.
|
| 25 |
Thiel C, Thiel K, Klingert W, et al. The enterohepatic circulation of amanitin: kinetics and therapeutical implications[J]. Toxicol Lett, 2011, 203 (2): 142-146.
|
| 26 |
Diaz JH. Amatoxin-containing mushroom poisonings: species, toxidromes, treatments, and outcomes[J]. Wilderness Environ Med, 2018, 29 (1): 111-118.
|
| 27 |
李启，雷永良，宋瑞强，等.鹅膏肽类毒素质谱检测方法的研究进展[J].实用预防医学，2015，22(11):1403-1407.
|
| 28 |
中国医师协会急诊医师分会，中国急诊专科医联体，中国医师协会急救复苏和灾难医学专业委员会，等.中国蘑菇中毒诊治临床专家共识[J].临床急诊杂志，2019，20(8):583-598.
|
| 29 |
Garcia de la Fuente I, McLin VA, Rimensberger PC, et al. Amanita poisoning and liver transplantation: do we have the right decision criteria?[J]. J Pediatr Gastroenterol Nutr, 2011, 53 (4): 459-462.
|
| 30 |
Ye Y, Liu Z. Management of Amanita phalloides poisoning: a literature review and update[J]. J Crit Care, 2018 (46): 17-22.
|
| 31 |
Bernuau JR, Francoz C, Durand F. Amatoxin poisoning: immediate transfer to intensive care or liver unit of patients at early risk of severe acute liver injury[J]. Liver Int, 2019, 39 (6): 1016-1018.
|
| 32 |
Han X, Cao Y, Chen Z. Detection of α-amanitin can guide the treatment of mushroom poisoning[J]. Toxicon, 2019 (158): S32.
|
| 33 |
Vale JA. Position statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists[J]. J Toxicol Clin Toxicol, 1997, 35 (7): 711-719.
|
| 34 |
Sun J, Zhang HS, Li HJ, et al. A case study of Lepiota brunneoincarnata poisoning with endoscopic nasobiliary drainage in Shandong, China[J]. Toxicon, 2019 (161): 12-16.
|
| 35 |
Pillukat MH, Schomacher T, Baier P, et al. Early initiation of MARS® dialysis in Amanita phalloides-induced acute liver injury prevents liver transplantation[J]. Ann Hepatol, 2016, 15 (5): 775-787.
|
| 36 |
Feinfeld DA, Rosenberg JW, Winchester JF. Three controversial issues in extracorporeal toxin removal[J]. Semin Dial, 2006, 19 (5): 358-362.
|
| 37 |
Tan L, He R, Li Y, et al. Fabrication of a biomimetic adsorbent imprinted with a common specificity determinant for the removal of α- and β-amanitin from plasma[J]. J Chromatogr A, 2016 (1459): 1-8.
|
| 38 |
Rifai K. Fractionated plasma separation and adsorption: current practice and future options[J]. Liver Int, 2011 (31 Suppl 3): 13-15.
|
| 39 |
Stankiewicz R, Lewandowski Z, Kotulski M, et al. Effectiveness of fractionated plasma separation and absorption as a treatment for amanita phalloides poisoning[J]. Ann Transplant, 2016 (21): 428-432.
|
| 40 |
Zheleva A, Tolekova A, Zhelev M, et al. Free radical reactions might contribute to severe alpha amanitin hepatotoxicity--a hypothesis[J]. Med Hypotheses, 2007, 69 (2): 361-367.
|
| 41 |
Mengs U, Pohl RT, Mitchell T. Legalon® SIL: the antidote of choice in patients with acute hepatotoxicity from amatoxin poisoning[J]. Curr Pharm Biotechnol, 2012, 13 (10): 1964-1970.
|
| 42 |
Wu H, Tang S, Huang Z, et al. Hepatoprotective effects and mechanisms of action of triterpenoids from lingzhi or reishi medicinal mushroom ganoderma lucidum (agaricomycetes) on alpha-amanitin-induced liver injury in mice[J]. Int J Med Mushrooms, 2016, 18 (9): 841-850.
|
| 43 |
Garcia J, Costa VM, Carvalho AT, et al. A breakthrough on Amanita phalloides poisoning: an effective antidotal effect by polymyxin B[J]. Arch Toxicol, 2015, 89 (12): 2305-2323.
|
| 44 |
孟庆义.毒蕈中毒的临床诊断与治疗[J].中国临床医生，2012，40(8):5-8.
|
| 45 |
Trakulsrichai S, Sriapha C, Tongpoo A, et al. Clinical characteristics and outcome of toxicity from Amanita mushroom poisoning[J]. Int J Gen Med, 2017 (10): 395-400.
|
| 46 |
Ganzert M, Felgenhauer N, Zilker T. Indication of liver transplantation following amatoxin intoxication[J]. J Hepatol, 2005, 42 (2): 202-209.
|
| 47 |
Giannini L, Vannacci A, Missanelli A, et al. Amatoxin poisoning: a 15-year retrospective analysis and follow-up evaluation of 105 patients[J]. Clin Toxicol (Phila), 2007, 45 (5): 539-542.
|